Logo Image
News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademyShortsSponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Events
Webcasts
Event Calendar

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Events
  • Subscribe
  • Event Calendar
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
Clinical Operations & Strategy|
Patient Participation
Advertisement

Jonathan Cotliar

Advertisement

Chief Medical Officer for Science 37

Articles by Jonathan Cotliar

Five Key Considerations for Designing and Implementing Decentralized Clinical Trials

ByJonathan Cotliar
August 10th 2021

Strategies and considerations for adopting decentralized clinical trials.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Applied Clinical Trials Online

    1

    FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy

    2

    ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation

    3

    ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion

    4

    Bringing the Voice of Clinical Practice and Patients into Drug Development

    5

    AI-Enabled Sites and the Future of Trial Planning: Q&A with Liz Beatty, Inato

    • About
    • Advertise
    • Contact Us
    • Editorial Contacts
    • Do Not Sell My Personal Information
    • Privacy Policy
    • Terms and Conditions
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    • Applied Clinical Trials
    • BioPharm International
    • Cannabis Science and Technology
    • Chromatography Online
    • Nutritional Outlook
    • Pharmaceutical Commerce
    • Pharmaceutical Executive
    • Pharm Tech
    • Spectroscopy Online
    • Turbo Machinery Magazine
    IS1
    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us